Veterinary Diagnostics Market Size & Growth Forecast 2027–2036, By Segments (Animal Type, Product, End-use, Testing Category), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Veterinary Diagnostics Market size was around USD 9.3 billion in 2026 and is slated to grow at a 10.45% CAGR from 2027 to 2036, crossing USD 25.13 billion by 2036. The industry revenue for 2027 is calculated at USD 10.12 billion.
Get more details on this report
Request Free Sample ReportVeterinary Diagnostics Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 40.55% market share in 2026, supported by established animal healthcare infrastructure, broad diagnostic testing availability, and consistently high spending on companion animal care.
- Asia Pacific is forecast to expand at an 11.31% CAGR, driven by greater animal health awareness, expanding veterinary services, and increasing diagnostic testing across companion animal and livestock care.
Segment Momentum
- Companion Animals held a 62.22% share in 2026, supported by frequent veterinary visits, routine screening, disease monitoring, and greater use of preventive diagnostic testing.
- Consumables, Reagents & Kits are the fastest-growing product segment because routine diagnostic workflows require continuous replenishment, with rising testing volumes driving recurring demand rather than one-time purchases.
Market Expansion Drivers
- Rising pet adoption and preventive animal healthcare increasing demand for routine diagnostic testing.
- Growing incidence of zoonotic and livestock diseases accelerating adoption of advanced veterinary diagnostics.
- Expanding molecular diagnostic capabilities improving accuracy and speed of veterinary disease detection.
Leading Market Participants
- Prominent players in the veterinary diagnostics market include IDEXX Laboratories, Inc. (United States), Zoetis Inc. (United States), Antech Diagnostics, Inc. (United States), FUJIFILM Corporation (Japan), Virbac S.A. (France), Esaote S.p.A. (Italy), Embark Veterinary, Inc. (United States), Innovative Diagnostics SAS (France), Agrolabo S.p.A. (Italy).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 9.3 billion
- 2027 Estimated Market Size: USD 10.12 billion.
- Projected Market Size: USD 25.13 billion by 2036
- Growth Forecast: 10.45% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Companion Animals (Animal Type) | Consumables, Reagents & Kits (Product) | Veterinarians (End-use) | Clinical Chemistry (Testing Category)
- Emerging Opportunity Segment: Production Animals (Animal Type) | Consumables, Reagents & Kits (Product) | Animal Owners/ Producers (End-use) | Cytopathology (Testing Category)
Market Growth Drivers and Industry Trends
Rising pet adoption and preventive animal healthcare increasing demand for routine diagnostic testing
Higher rates of pet ownership and greater awareness of preventive animal healthcare are strengthening demand across the veterinary diagnostics market, as owners increasingly seek regular health screening rather than relying solely on diagnostic testing after symptoms emerge. Routine blood tests, urinalysis, imaging, and other screening procedures support early identification of infections, metabolic disorders, nutritional deficiencies, and chronic conditions, enabling veterinarians to initiate treatment at an earlier stage. The growing emphasis on animal wellness, regular veterinary visits, and preventive care is also encouraging clinics to expand their diagnostic capabilities and incorporate testing into standard health examinations, particularly for companion animals requiring ongoing monitoring.
Growing incidence of zoonotic and livestock diseases accelerating adoption of advanced veterinary diagnostics
The increasing occurrence of diseases affecting both animals and humans is creating a stronger need for rapid and reliable disease surveillance, supporting veterinary diagnostics market growth across companion animal, livestock, and agricultural settings. Zoonotic infections require timely identification to reduce transmission risks, while disease outbreaks among livestock can affect herd health, productivity, food supply, and animal trade. These concerns are encouraging veterinarians, farms, and animal health authorities to adopt diagnostic tools that can identify pathogens more efficiently and support appropriate treatment and containment decisions. Greater attention to biosecurity and disease monitoring is further increasing the role of diagnostic testing in routine livestock management and outbreak response.
Expanding molecular diagnostic capabilities improving accuracy and speed of veterinary disease detection
Advancements in molecular testing are enhancing the ability of veterinary diagnostics market participants to identify pathogens and disease conditions with greater precision and shorter turnaround times. Techniques based on nucleic acid detection can help distinguish closely related infectious agents and detect diseases at earlier stages, supporting more targeted clinical decisions and disease-control measures. Improved laboratory workflows, portable testing technologies, and the broader availability of molecular assays are also making sophisticated diagnostics more practical across veterinary clinics, laboratories, and animal production environments. These capabilities are particularly valuable where rapid identification is necessary to guide treatment, isolate affected animals, or monitor the spread of infectious diseases.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising pet adoption and preventive animal healthcare increasing demand for routine diagnostic testing | 2.00% | Moderate | North America, Asia Pacific, Europe | High | Near Term |
| Growing incidence of zoonotic and livestock diseases accelerating adoption of advanced veterinary diagnostics | 1.80% | High | Asia Pacific, North America | High | Mid Term |
| Expanding molecular diagnostic capabilities improving accuracy and speed of veterinary disease detection | 1.60% | Moderate | North America, Europe | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America accounted for 40.55% of the veterinary diagnostics market in 2026, supported by advanced veterinary healthcare infrastructure, high awareness of animal health, and broad adoption of laboratory and point-of-care diagnostic technologies. Increasing emphasis on preventive veterinary care and early disease identification is encouraging greater use of diagnostic testing across companion and production animals. Established veterinary practices, sophisticated laboratory capabilities, and continued integration of digital and molecular diagnostic methods further strengthen regional demand. Growing attention to animal disease surveillance and healthcare outcomes also supports the region’s established market position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific represents the fastest-growing regional market, driven by expanding veterinary healthcare infrastructure, rising pet ownership, and increasing awareness of animal disease prevention. Growing livestock production is also creating demand for reliable diagnostic tools that can support disease detection, herd health management, and productivity. Improvements in veterinary laboratories, greater accessibility to diagnostic technologies, and increasing investment in animal healthcare are broadening the regional customer base. Rising adoption of preventive veterinary practices is further creating favorable conditions for market expansion.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Laboratory NetworksGermany emphasizes high-quality veterinary diagnostics supported by established laboratory infrastructure and stringent testing standards. Veterinary providers in Germany continue adopting advanced diagnostic technologies that improve disease detection, herd health management, and clinical decision-making.
France 🇫🇷
Livestock Health MonitoringFrance supports veterinary diagnostics through strong demand from both livestock management and companion animal healthcare. Diagnostic laboratories in France continue expanding testing capabilities that enhance disease surveillance, preventive care, and veterinary treatment planning.
Italy 🇮🇹
Integrated Clinical TestingItaly is reinforcing veterinary diagnostics through broader adoption of laboratory testing across companion animal clinics and livestock operations. Veterinary professionals in Italy increasingly rely on advanced diagnostic tools to improve clinical accuracy and support efficient treatment pathways.
Japan 🇯🇵
Companion Animal ScreeningJapan is strengthening the veterinary diagnostics market through increasing demand for routine health screening and early disease detection in companion animals. Diagnostic providers in Japan focus on accurate, minimally invasive testing solutions that integrate efficiently into veterinary clinical practice.
South Korea 🇰🇷
Digital Veterinary SolutionsSouth Korea is integrating digital technologies into veterinary diagnostics to improve laboratory efficiency and diagnostic accuracy. Veterinary clinics in South Korea increasingly adopt automated analyzers and rapid testing platforms to support comprehensive animal healthcare services.
United States 🇺🇸
Advanced Diagnostic AdoptionThe U.S. veterinary diagnostics market is expanding through greater use of molecular testing, point-of-care diagnostics, and digital laboratory platforms. Veterinary practices in the U.S. increasingly prioritize faster diagnostic workflows that support preventive care and timely treatment decisions for companion and livestock animals.
Segment Leadership and Growth Trends
Veterinary Diagnostics Market Share (%), by Animal Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportAnimal Type Segment Analysis: Companion Animals (Largest Segment) vs Production Animals (Fastest-Growing Segment)
Companion animals held the largest share of the veterinary diagnostics market in 2026, accounting for 62.22%. Growing pet ownership and increasing attention to preventive animal healthcare are strengthening demand for diagnostic testing among dogs, cats, and other household animals. Pet owners are becoming more willing to pursue routine health assessments, early disease detection, and laboratory testing, while veterinary practices are expanding their use of diagnostic technologies to support more accurate and timely clinical decisions. The humanization of pets and greater emphasis on maintaining animal health are therefore reinforcing demand across this segment.
Production animals represent the fastest-growing animal type segment as livestock producers place greater emphasis on disease prevention, herd health, productivity, and food safety. Diagnostic testing enables earlier identification of infections and health problems, supporting more effective disease management and reducing the potential impact of illness across animal populations. Increasing adoption of data-driven livestock management and the need to maintain healthy production systems are encouraging broader use of veterinary diagnostic solutions in agricultural settings.
Product Segment Analysis: Consumables, Reagents & Kits (Largest & Fastest-Growing Segment)
Consumables, reagents & kits represented the largest and fastest-growing product segment in the veterinary diagnostics market in 2026, accounting for a 55.61% share. These products are integral to routine diagnostic workflows because testing procedures require recurring supplies for sample preparation, analysis, and detection. Their continued use across veterinary laboratories, clinics, and animal healthcare facilities creates sustained demand, while increasing diagnostic testing volumes and the wider adoption of rapid and laboratory-based testing are supporting further expansion. Growing emphasis on early disease identification and preventive veterinary care is also increasing the frequency with which these products are utilized.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Animal Type | Production Animals, Companion Animals | Companion Animals | Production Animals |
| Product | Consumables, Reagents & Kits, Equipment & Instruments | Consumables, Reagents & Kits | Consumables, Reagents & Kits |
| End-use | Reference Laboratories, Veterinarians, Animal Owners/ Producers | Veterinarians | Animal Owners/ Producers |
| Testing Category | Clinical Chemistry, Microbiology, Parasitology, Histopathology, Cytopathology, Hematology, Immunology & Serology, Imaging, Molecular Diagnostics, Others | Clinical Chemistry | Cytopathology |
Competitive Landscape and Market Positioning
Leading companies in the veterinary diagnostics market:
1. IDEXX Laboratories Inc. (United States)
2. Zoetis Inc. (United States)
3. Antech Diagnostics Inc. (United States)
4. FUJIFILM Corporation (Japan)
5. Virbac S.A. (France)
6. Esaote S.p.A. (Italy)
7. Embark Veterinary Inc. (United States)
8. Innovative Diagnostics SAS (France)
9. Agrolabo S.p.A. (Italy)
The veterinary diagnostics market is rapidly evolving with the introduction of AI-assisted testing systems, rapid diagnostic kits, and advanced imaging technologies that improve clinical decision-making. Ongoing research efforts are enhancing diagnostic speed, accuracy, and portability for veterinary applications across companion and livestock animals. Growing emphasis on preventive animal healthcare and disease monitoring is also fueling continuous product development within the sector.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| IDEXX Laboratories Inc. (United States) | |||||||
| Zoetis Inc. (United States) | |||||||
| Antech Diagnostics Inc. (United States) | |||||||
| FUJIFILM Corporation (Japan) | |||||||
| Virbac S.A. (France) | |||||||
| Esaote S.p.A. (Italy) | |||||||
| Embark Veterinary Inc. (United States) | |||||||
| Innovative Diagnostics SAS (France) | |||||||
| Agrolabo S.p.A. (Italy). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| HT VET | Jan-26 | HT VET launched an AI-powered, noninvasive diagnostic device for canine cancer detection. This technological integration represents a significant advancement in veterinary oncology, enabling earlier and more accessible disease screening and providing veterinarians with enhanced clinical capabilities for diagnosing dermal and subcutaneous masses. |
| KVP International | Dec-25 | KVP International acquired SafePath Laboratories and IVD Research (SafePath-IVD). This transaction strengthens the company’s capabilities in veterinary diagnostics, expanding its portfolio of in-vitro diagnostic solutions and diversifying its technological reach across both animal and human health markets. |
| MI:RNA | Dec-25 | MI:RNA completed an oversubscribed funding round to accelerate the commercialization of its molecular veterinary diagnostic technologies. By leveraging advanced biomarker modeling for early disease detection, the company is scaling its operational capabilities to meet growing demand for precise, early-stage diagnostics in the animal health market. |
| Zoetis | Nov-25 | Zoetis acquired Veterinary Pathology Group (VPG), a prominent laboratory network operating across the UK and Ireland. This acquisition significantly expands the company's diagnostics footprint and enhances its capacity to deliver high-quality, specialized diagnostic services, strengthening its competitive positioning within the global animal health diagnostics sector. |
| IMV Imaging | Sep-25 | IMV Imaging formed a strategic partnership with Asto CT to integrate ultrasound, X-ray, and MRI tools with advanced standing CT scanner technology for horses. This collaboration enhances the diagnostic ecosystem for equine and mixed-animal practices, providing a comprehensive, specialized imaging solution for complex veterinary cases. |
| Eagle Diagnostics | Apr-25 | Eagle Diagnostics acquired the Equine Analytical Chemistry Laboratory from the University of Kentucky, rebranding it as Equine Integrity and Anti-Doping Sciences (EQIAS) Labs. This acquisition secures a key facility in anti-doping testing and provides a platform for the company to accelerate research and innovation in specialized equine veterinary diagnostics. |
| University of Missouri | Apr-25 | The University of Missouri College of Veterinary Medicine initiated development of the Dr. Dan Brown Building to house its Veterinary Medical Diagnostics Laboratory. This expansion of physical infrastructure significantly increases the institution's diagnostic capacity and testing throughput, supporting broader clinical service delivery for veterinary diagnostic providers. |
| Zoetis | Sep-24 | Zoetis introduced Vetscan OptiCell, a cartridge-based hematology analyzer utilizing AI-driven technology to perform complete blood counts at the point of care. This innovation improves diagnostic efficiency, offering laboratory-quality results with reduced time, space, and cost requirements, thereby optimizing clinical workflow for veterinary practitioners. |
| Virginia Equine Imaging | Jul-24 | Virginia Equine Imaging integrated the Asto CT Equina standing CT scanner into its clinical operations. This adoption of advanced imaging technology expands the facility’s diagnostic throughput and quality for equine patients, strengthening the provider's competitive advantage in specialized equine medical care. |
| Veterinary Specialists of Sydney | Jun-24 | Veterinary Specialists of Sydney deployed Australia’s first mobile CT scanner for veterinary use. This expansion of advanced imaging infrastructure improves accessibility to high-resolution diagnostic tools for pets across a wider geographic area, representing a significant improvement in regional diagnostic service delivery and clinical capabilities. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Veterinary Diagnostics Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Disease Indication | Infectious Diseases, Chronic & Metabolic Diseases, Parasitic Diseases, Genetic & Hereditary Diseases, Reproductive & Other Diseases |
| Care Setting | Veterinary Clinics & Hospitals, Reference Laboratories, Point-of-Care Settings |
| Testing Workflow | Point-of-Care Testing, In-House Laboratory Testing, Centralized Laboratory Testing |
Veterinary Diagnostics Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Animal Disease Surveillance Opportunity Assessment |
|
| Veterinary Testing Adoption Landscape |
|
| Diagnostic Workflow Transformation Assessment |
|
Need a different cut of the data?
Request Custom ResearchWhat is the market size of veterinary diagnostics?
How will the veterinary diagnostics industry grow in terms of size and CAGR by 2036?
How is rising pet adoption influencing demand in the veterinary diagnostics market?
How are disease risks and molecular diagnostics shaping veterinary testing adoption trends?
Why are Companion Animals the largest animal type segment in the veterinary diagnostics market?
Why are Consumables, Reagents & Kits the fastest-growing product segment in the veterinary diagnostics market?
Why is North America the largest veterinary diagnostics market?
What factors are accelerating veterinary diagnostics market growth in Asia Pacific?
Which organizations are considered leaders in the veterinary diagnostics landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization